Skip to content
Search

Latest Stories

Sigma Community Pharmacy Conference: Celebrating The Heart of Healthcare

Sigma Community Pharmacy Conference: Celebrating The Heart of Healthcare

Community pharmacies are essential pillars of healthcare provision and our communities, says Lord Popat

The Sigma Community Pharmacy Conference kicked off with a powerful and insightful speech by Lord Popat, setting the tone for a day dedicated to recognising and celebrating the pivotal role that community pharmacies play in our society. His opening remarks not only expressed gratitude but also underscored the importance of community pharmacies in the fabric of our healthcare system.


Lord Popat's gratitude extended beyond the immediate audience, recognizing the collaborative efforts that bring such conferences to life. Dr. Bharat Shah's role in making the event possible highlighted the interconnectedness of the healthcare community, setting the stage for a day of shared insights and collaboration.

In his address, Lord Popat shed light on the critical role community pharmacies play in our society. Community pharmacies, he emphasised, are more than just dispensaries—they are essential pillars of healthcare provision and our communities. Acting as the first point of contact for medical advice, prescription medications, and various healthcare services, they alleviate the pressure on GP waiting times and ensure timely access to treatment for minor illnesses.

Lord Popat acknowledged the exceptional role community pharmacies played during the COVID-19 pandemic. From dispensing vaccines to offering guidance on public health measures, pharmacists stood on the front lines, showcasing their resilience, dedication, and contribution to community well-being.

Beyond healthcare services, community pharmacies serve as community hubs. They provide a welcoming environment for individuals to seek guidance, build relationships, and access reliable healthcare information. The personal connections developed between pharmacists and customers foster trust and create a space where individuals feel comfortable seeking advice and support for their health concerns.

A message from the Prime Minister was read out by Lord Popat, emphasizing the government's appreciation for the hard work of pharmacy teams. The government's commitment to supporting community pharmacies was evident in the announced investment of up to £645 million over the next two years to bolster the Pharmacy First service for patients.

This investment enables community pharmacists to play an even more significant role by assessing patients and providing treatment options without the need for a GP's appointment. The Prime Minister acknowledged the vital role community pharmacies play in maintaining and caring for local communities, extending personal gratitude to everyone providing these essential services daily.

In conclusion, the Sigma Community Pharmacy Conference opened with a powerful recognition of the indispensable role community pharmacies play in our healthcare system.

Lord Popat and the Prime Minister collectively conveyed gratitude and support, acknowledging the tireless efforts of community pharmacists. As we navigate the challenges of healthcare, let us recognize and appreciate these cornerstones of our communities, whose accessibility, expertise, and diverse range of services contribute significantly to the well-being of individuals from all walks of life. The conference promises to be a platform for sharing insights, fostering collaboration, and collectively working towards a healthier future.

More For You

How to leverage data to drive pharmacy growth

Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy.

Pharmacy challenges: How data can help spot the ‘elephant in the room’

Adopting new technologies is vital for moving pharmacy forward — but are you fully harnessing the data these tools generate?

“Being able to utilise, manage, and interpret the data these technologies provide can help add more value to your business,” said Adele Curran, chief operating officer at Real World Analytics (RWA) Pharmacy, while speaking at the recent Pharmacy Business Conference.

Keep ReadingShow less
Branded OTC products can boost pharmacy revenue and promote self-care, says PAGB CEO

Michelle Riddalls

How branded OTC products can help struggling community pharmacies - PAGB chief explains

Branded over-the-counter (OTC) products could play a vital role in promoting self-care and supporting the sustainability of community pharmacies, said Michelle Riddalls, CEO of PAGB – the consumer healthcare association – during the recent Pharmacy Business Conference.

Riddalls emphasised that OTC medicines not only enable consumers to better manage their health through self-care but also offer pharmacies an opportunity to increase revenue, particularly during a time of mounting financial pressure.

Keep ReadingShow less
How Peptides Are Transforming Modern Drug Development

Modern Drug Development

How Peptides Are Transforming Modern Drug Development

The pharmaceutical industry is rapidly evolving, embracing new technologies and methodologies. Peptides are emerging as a crucial component in this transformation, offering innovative solutions to drug development. This shift is not only reshaping how drugs are discovered but also enhancing their efficacy and safety.

In recent years, the pharmaceutical landscape has undergone significant changes, driven by advancements in technology and scientific understanding. One of the most promising areas of innovation is the use of peptides in drug development. These short chains of amino acids have proven to be versatile tools, capable of targeting specific cells or molecules with high precision. In this context, certain bpc 157 peptide research peptides have been highlighted for their potential applications in various therapeutic areas, showcasing the promise that peptides hold for modern pharmaceutical studies.

Keep ReadingShow less
Off-patent medicines could save NHS millions—but only if UK remains attractive to suppliers - BGMA

BGMA chief executive Mark Samuels urges government to back off-patent medicines ahead of Life Sciences Plan release.

UK risks losing millions in NHS savings without stronger support for generics - BGMA

The British Generic Manufacturers Association (BGMA) has called on the government to create a more supportive environment for the generics and biosimilars sector, warning that the UK risks missing out on significant NHS savings arising from new off-patent medicines.

According to the BGMA, 31 medicines are due to lose patent protection between January and June 2025, with a further 28 set to follow in the second half of the year.

Keep ReadingShow less
Support for generic medicines manufacturers key to affordable healthcare- Teva UK director

Teva UK sounds alarm on accelerating consolidation of critical generic medicines

Photo credit: gettyimages

Exclusive: Teva UK calls for inclusion of generic manufacturers in policy talks

A healthy and vibrant generics marketplace supports not only patients but also contributes billions of pounds in savings to the drugs bill. However, growing pressures on generic medicine manufacturers could threaten this vital part of the healthcare ecosystem, warns Ryan Ruscoe, senior director of generics and OTC at Teva UK.

Speaking exclusively to Pharmacy Business, Ruscoe stressed the urgent need to address supply chain vulnerabilities, particularly for critical generic medicines.

Keep ReadingShow less